CIK 0001808898 · Non-accelerated filer<br>Smaller reporting company
Benitec Biopharma Inc.
Sign in to watch- Ticker
- BNTC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- Phone
- (510) 780-0819
- Business address
- 3940 TRUST WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-09 | Mehta Kishan Director | Grant or award · Options (right to buy) | +35,000 | 35,000 | ||
| 2024-12-09 | Francis Peter Director | Grant or award · Options (right to buy) | +35,000 | 35,000 | ||
| 2024-12-09 | BUCHI J KEVIN Director | Grant or award · Options (right to buy) | +35,000 | 35,000 | ||
| 2024-12-09 | Smith Edward F Director | Grant or award · Options (right to buy) | +35,000 | 35,000 | ||
| 2024-12-09 | Banks Jerel A. Chief Executive Officer | Grant or award · Options (right to buy) | +2,310,000 | 2,310,000 | ||
| 2024-12-09 | Boston Megan Executive Director | Grant or award · Options (right to buy) | +720,000 | 720,000 | ||
| 2024-12-03 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +37,190 | $9.60 | $357K | 7,957,365 |
| 2024-12-03 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +4,810 | $9.60 | $46K | 955,124 |
| 2024-11-20 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +24,360 | $10.22 | $249K | 7,920,175 |
| 2024-11-20 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +3,076 | $10.22 | $31K | 950,314 |
| 2024-11-19 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +12,430 | $9.73 | $121K | 7,895,815 |
| 2024-11-19 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Purchase | +1,570 | $9.73 | $15K | 947,238 |
| 2024-09-26 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Option exercise | +588,236 | $1.93 | $1.1M | 2,058,415 |
| 2024-09-26 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Option exercise | +4,605,000 | $3.86 | $17.8M | 6,663,415 |
| 2024-09-26 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Option exercise | +1,219,970 | $0.00 | $122 | 7,883,385 |
| 2024-09-26 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Option exercise | +576,347 | $3.86 | $2.2M | 797,458 |
| 2024-09-26 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Option exercise | +148,210 | $0.00 | $15 | 945,668 |
| 2024-09-26 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Option exercise · Series 2 Common Warrants | −10,000,000 | 0 | ||
| 2024-09-26 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Option exercise · Common Warrants | −4,605,000 | 0 | ||
| 2024-09-26 | SUVRETTA CAPITAL MANAGEMENT, LLC Director | Option exercise · Pre-Funded Warrants | −1,219,970 | 3,385,030 |
Page 3 of 5 · 90 trades